![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07K 16/28 | (2006.01) |
A61K 39/395 | (2006.01) | ||
A61P 37/06 | (2006.01) | ||
A61P 19/02 | (2006.01) |
(11) | Number of the document | 2315780 |
(13) | Kind of document | T |
(96) | European patent application number | 09797499.2 |
Date of filing the European patent application | 2009-07-15 | |
(97) | Date of publication of the European application | 2011-05-04 |
(45) | Date of publication and mention of the grant of the patent | 2015-08-19 |
(46) | Date of publication of the claims translation | 2015-11-25 |
(86) | Number | PCT/EP2009/059030 |
Date | 2009-07-15 |
(87) | Number | WO 2010/007082 |
Date | 2010-01-21 |
(30) | Number | Date | Country code |
08160671 | 2008-07-17 | EP | |
09160326 | 2009-05-15 | EP |
(72) |
HEUSSER, Christoph, CH
NEUGEBAUER, Julia, DE
SCHAADT, Eveline, DE
URLINGER, Stefanie, DE
WOISETSCHLAEGER, Maximilian, AT
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Kompozicijos ir būdai, skirti terapinių antikūnų panaudojimui |
COMPOSITIONS AND METHODS OF USE FOR THERAPEUTIC ANTIBODIES |
Payment date | Validity (years) | Amount | |
2025-06-18 | 17 | 347.00 EUR |
2026-07-15 |